to

CannaBiz Invest Asia

1 Sukhumvit 22 Klongton,
Holiday Inn Bangkok Sukhumvit,
Bangkok, Thailand

Details

Attend CMT’s CannaBiz Invest Asia Summit on 29-30 Aug 2019 in Bangkok to gain a first mover advantage in a burgeoning markets in Asia! Meet who’s who in the medical cannabis value chain.

Aurora Cannabis shares Global cannabis market outlook & investment landscape

Find out from Tilleke & Gibbins the medical cannabis investment landscape & regulatory hurdles in Thailand

Dept of Thai Traditional and Alternative Medicine, Ministry of Public Health highlights integration of medical cannabis in thai traditional medicine - a balancing game

Learn about China – industrial hemp cultivation & value chain investment case study from CannAcubed

BOL Pharma provides insights from farm to pharmaceutical products – Israel’s experience

Growth outlook for hemp foods, protein and the CBD market in Japan and globally by Elixinol Global

Hikurangi Cannabis Company shares Cannabis legislation in New Zealand: including government efforts to design world-leading medicinal cannabis and full legalisation

Commercialization of plant-derived cannabinoid prescription medicines to meet global demand by MGC Pharmaceuticals

Jacana provides views on “green green profits” - the cultivation of outdoor medical cannabis as a business model for Asia

Bombay Hemp Company Private Limited (BOHECO)provides update on industrial and medical cannabis investment in India – scientific and legal perspective

Vital panel discussion on  accessing capital markets for cannabis investments – options & challenges by MYM Nutraceuticals, Helius Therapeutics, Cannex Group & more!  

Blue Sky Biologicals provides insights on Hemp: beyond CBD & THC, a whole plant model

The Kingdom Holdings shares the future of sustainable fashion & hemp fibres industry

Pharmaceutical development in man-made cannabinoids by Akseera Pharma Corp

Outlook of medical cannabis industry in Australia

Potential of CBD in Beauty industry

Cannabis varieties and strains as well as extraction technologies

Program

08:00 Aug 29
Morning Registrations & Coffee
09:00 Aug 29
Chairman’s Welcome & Introduction
09:10 Aug 29
INTEGRATION OF MEDICAL CANNABIS IN THAI TRADITIONAL MEDICINE - A BALANCING GAME
Dr. Khwanchai Visithanon, Director Dept of Thai Traditional and Alternative Medicine, Ministry of Health
09:40 Aug 29
UNDERSTANDING THE MEDICAL CANNABIS INVESTMENT LANDSCAPE & REGULATORY HURDLES IN THAILAND
Dr. Atthachai Homhuan, Manager, Regulatory Affairs Tilleke & Gibbins International Ltd
10:10 Aug 29
CHINA – INDUSTRIAL HEMP CULTIVATION & VALUE CHAIN INVESTMENT CASE STUDY
Mr. Glenn Davies, Co-Founder & Group CEO CannAcubed Pte Ltd
10:40 Aug 29
Networking Refreshment
11:10 Aug 29
GLOBAL CANNABIS MARKET OUTLOOK & INVESTMENT LANDSCAPE
Cam Battley, Chief Corporate Officer Aurora Cannabis Inc.
11:40 Aug 29
FROM FARM TO PHARMACEUTICAL PRODUCTS – ISRAEL’S EXPERIENCE
Dr. Tamir Gedo, CEO BOL Pharma Ltd
12:10 Aug 29
GROWTH OUTLOOK FOR HEMP FOODS, PROTEIN & THE CBD MARKET IN JAPAN & GLOBALLY
Mr. Paul Benhaim, CEO Elixinol Global Ltd
12:40 Aug 29
Networking Lunch
13:45 Aug 29
Afternoon Chairman’s Introduction
13:50 Aug 29
ACCESSING CAPITAL MARKETS FOR CANNABIS INVESTMENTS – OPTIONS & CHALLENGES
Panelists: Erick Factor, Executive Chairman & Founder MYM Nutraceuticals, Paul Manning, Co founder and Excutive Director Helius Therapeutics, Anthony Dutton, CEO Cannex Capital
14:20 Aug 29
CANNABIS LEGISLATION IN NEW ZEALAND: REFLECTIONS ON GOVERNMENT EFFORTS TO DESIGN WORLD-LEADING MEDICINAL CANNABIS & FULL LEGALISATION
Mr. Manu Caddie, CEO Hikurangi Cannabis Company
14:50 Aug 29
OUTLOOK OF THE MEDICAL CANNABIS INDUSTRY IN AUSTRALIA
15:20 Aug 29
Networking Refreshment
15:50 Aug 29
HEMP: BEYOND CBD & THC, A WHOLE PLANT MODEL
Preet Marwaha, CEO Blue Sky Biologicals
16:20 Aug 29
THE FUTURE OF SUSTAINABLE FASHION & HEMP FIBRES INDUSTRY
Mr. Andy Chan, CFO Kingdom Holdings Limited
16:50 Aug 29
CBD – THE NEXT BIG THING IN BEAUTY?
17:20 Aug 29
End of Day One
09:00 Aug 30
Chairman’s Introduction
09:10 Aug 30
INDUSTRIAL AND MEDICAL CANNABIS INVESTMENT IN INDIA – SCIENTIFIC AND LEGAL PERSPECTIVE
Mr. Jahan Peston Jamas, Co-founder & & Director, Strategic Development and Collaborations Bombay Hemp Company Private Limited (BOHECO)
09:40 Aug 30
“GREEN GREEN PROFITS” - THE CULTIVATION OF OUTDOOR MEDICAL CANNABIS AS A BUSINESS MODEL FOR ASIA
Mr. Markus Hoffmann, VP of Business Development Jacana Holdings Inc.
10:10 Aug 30
LATEST EXTRACTION & REFINING TECHNOLOGIES - PERSPECTIVE FROM BIOTECH COMPANIES
10:40 Aug 30
Networking Refreshment
11:10 Aug 30
CANNABIS SEEDS & STRAINS SELECTION
11:40 Aug 30
COMMERCIALIZATION OF PLANT-DERIVED CANNABINOID PRESCRIPTION MEDICINES TO MEET GLOBAL DEMAND
Mr. Blaise Bratter, Australia Operations Manager MGC Pharmaceuticals Ltd
12:10 Aug 30
PHARMACEUTICAL DEVELOPMENT IN MAN-MADE CANNABINOIDS
Mr. Manit Patel, Chief Executive Officer Akseera Pharma Corp
12:40 Aug 30
Final Discussion followed by Closing Lunch

Tickets